000 01545 a2200433 4500
005 20250518053908.0
264 0 _c20200806
008 202008s 0 0 eng d
022 _a1098-6596
024 7 _a10.1128/AAC.00982-19
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWang, Qiao
245 0 0 _aUtility of Targeted, Amplicon-Based Deep Sequencing To Detect Resistance to First-Line Tuberculosis Drugs in Botswana.
_h[electronic resource]
260 _bAntimicrobial agents and chemotherapy
_c11 2019
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650 0 4 _aAdult
650 0 4 _aAntitubercular Agents
_xtherapeutic use
650 0 4 _aBotswana
650 0 4 _aFemale
650 0 4 _aHigh-Throughput Nucleotide Sequencing
_xmethods
650 0 4 _aHumans
650 0 4 _aIsoniazid
_xtherapeutic use
650 0 4 _aMale
650 0 4 _aMicrobial Sensitivity Tests
_xmethods
650 0 4 _aMiddle Aged
650 0 4 _aMycobacterium tuberculosis
_xdrug effects
650 0 4 _aPhenotype
650 0 4 _aSensitivity and Specificity
650 0 4 _aTuberculosis, Multidrug-Resistant
_xdrug therapy
650 0 4 _aYoung Adult
700 1 _aModongo, Chawangwa
700 1 _aAllender, Christopher
700 1 _aEngelthaler, David M
700 1 _aWarren, Robin M
700 1 _aZetola, Nicola M
700 1 _aShin, Sanghyuk S
773 0 _tAntimicrobial agents and chemotherapy
_gvol. 63
_gno. 11
856 4 0 _uhttps://doi.org/10.1128/AAC.00982-19
_zAvailable from publisher's website
999 _c29998941
_d29998941